Disc Medicine, Inc.

IRON Healthcare Biotechnology

In the quarter to June 2026, EPS grew 2.53%, free cash flow grew 7.83% and total debt rose 106.5%, each against the same quarter a year earlier.

56.80 0.15 +0.26%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '19 Jan '20 Dec '20 Jan '21 Dec '21 Jan '22 Dec '22 Dec '23 Dec '24 Dec '25
Current Ratio
— 0.20 0.20 6.74 6.74 8.79 8.79 17.06 21.17 21.94
Net Debt/EBITDA
— (0.51) (0.16) 0.00 2.84 0.00 4.11 3.96 3.42 3.12
Debt/Equity
— (0.99) (0.46) 0.00 (0.01) 0.00 0.00 0.00 0.06 0.04
ROE
— 0.00% 186.80% 0.00% 83.59% 0.00% (83.32%) (29.30%) (27.73%) (35.86%)
ROA
0.00% 0.00% (490.89%) 0.00% (71.42%) 0.00% (32.01%) (26.90%) (25.29%) (32.55%)
ROIC
— 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
— 209.24% 209.24% (45.64%) (46.61%) (26.38%) (26.59%) (22.19%) (23.22%) (27.61%)
Free Cash Flow per Share
— (21.64) (21.65) (31.35) (31.44) (40.65) (40.81) (3.30) (3.42) (5.14)
Book value per Share
— (14.46) (14.46) 88.40 (73.12) 169.89 169.97 15.47 16.07 20.96
Free Cash Flow
— (32.71) (32.73) (27.53) (27.60) (42.25) (42.40) (73.55) (94.43) (181.33)
Other line items

Show all line items

Columns are period end dates